• English 
    • español
    • English
    • français
  • FacebookPinterestTwitter
  • español
  • English
  • français
APh. vol. 67 (1) 
  •   DIGIBUG Home
  • 2.-Revistas
  • ARS Pharmaceutica
  • Ars Pharma 2026, Vol. 67
  • APh. vol. 67 (1)
  •   DIGIBUG Home
  • 2.-Revistas
  • ARS Pharmaceutica
  • Ars Pharma 2026, Vol. 67
  • APh. vol. 67 (1)
JavaScript is disabled for your browser. Some features of this site may not work without it.

APh. vol. 67 (1) (11)

Browse by

By Issue DateAuthorsTitlesSubjectFinanciación

Search within this collection:

 

Recent Submissions

  • Biosimilar eculizumab and meningococcal meningitis: the importance of strengthening health education 

    Fernández-Varela, Alba María; Villaverde Piñeiro, Laura; Álvarez Payero, Miriam (2025-12-20)
  • Beers, STOPP/START y PRISCUS: análisis crítico de su evolución y aplicabilidad en la prescripción geriátrica 

    Alemán-Fernández, Eliezer; Siverio-Mota, Dany; Vicet-Muro, Liliana; Delgado-Hernández, René; Machado Rivero, Manuel Osvaldo (2025-12-20)
  • Multi-Omics and Molecular Dynamics Simulation Reveal the Therapeutic Mechanisms of Cordyceps sinensis against Colorectal Cancer 

    Zhong, Xuemei; Wen, Jiaxin; Wei, Pengfei (2025-12-20)
  • Formulation and Evaluation of Oral Disintegrating Tablets of Enalapril Maleate Using Synthetic and Natural Superdisintegrants 

    Megavath, Swapna; Desu, Prasanna Kumar; Molla, Rahul; Kondi, Vanitha (2025-12-20)
  • Características clínicas y sociodemográficas de pacientes con alergia a betalactámicos: Revisión estructurada 

    Parra-González, María Antonia Valentina; Vargas-Martínez, Carlos Elías; Amariles, Pedro (2025-12-20)

View more

My Account

LoginRegister

Browse

All of DIGIBUGCommunities and CollectionsBy Issue DateAuthorsTitlesSubjectFinanciaciónAuthor profilesThis CollectionBy Issue DateAuthorsTitlesSubjectFinanciación

Statistics

View Usage Statistics

Servicios

Pasos para autoarchivoAyudaLicencias Creative CommonsSHERPA/RoMEODulcinea Biblioteca UniversitariaNos puedes encontrar a través deCondiciones legales

Contact Us | Send Feedback | RSS 1.0 | RSS 2.0 | Atom